MicroAlgo (VENAF) Current Deferred Revenue (2021 - 2025)

MicroAlgo (VENAF) has 5 years of Current Deferred Revenue data on file, last reported at $1.0 million in Q4 2025.

• For the quarter ending Q4 2025, Current Deferred Revenue rose 111.51% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (up 111.51% YoY), and the FY2025 full-year result was $1.0 million, up 113.59% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $1.0 million, up from $340193.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $4.6 million in Q1 2023 and bottomed at $340193.0 in Q2 2025.
• The 5-year median for Current Deferred Revenue is $992299.3 (2023), against an average of $1.3 million.
• The widest annual swing landed in 2023, when Current Deferred Revenue soared 164.97%; it then sank 67.05% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $1.9 million in 2021, then fell by 17.59% to $1.6 million in 2022, then decreased by 8.56% to $1.4 million in 2023, then slumped by 67.05% to $474686.3 in 2024, then jumped by 111.51% to $1.0 million in 2025.
• The last three Current Deferred Revenue figures came in at $1.0 million (Q4 2025), $340193.0 (Q2 2025), and $474686.3 (Q4 2024), per Business Quant data.

Peer Comparison